Retroscreen Virology Chief Scientist to speak at Respiratory Syncytial Virus Symposium 2014

November 6, 2014 1:49 pm

RSV 2014, Stellenbosch, South Africa, 9-13 Nov 2014

Leading human models of disease research company Retroscreen Virology has announced one of its leadership team will be speaking at 2014 Respiratory Syncytial Virus Symposium in South Africa.

Dr Rob Lambkin-Williams, Executive Scientific Advisor at Retroscreen Virology, is going to be talking about the Retroscreen hVIVO model, how it can be applied to help accelerate drug and vaccine development, and the transfer of data from Human Challenge studies to field studies.

The 9th Respiratory Syncytial Virus Symposium (“RSV 2014”), which takes place between 9-13th November 2014 in Stellenbosch, is the official conference of the RSV scientific community. The event welcomes a number of key industry speakers as well as an exhibition of pharmaceutical and medical equipment products. Retroscreen, who will be sponsoring an industry session on Tuesday 11th November between 18:00 – 20:00, specialise in the provision of clinical services to third party study sponsors, helping to accelerate drug development.

Established in 1988, the business was set up to commercialise the academic research of Professor John Oxford in the field of retroviruses. Early studies conducted at Retroscreen were led by Dr. Rob Lambkin-Williams and Dr. Anthony Gilbert, who were tasked with developing a series of well-characterised virus stocks whilst showing clients that the Human Viral Challenge Model is a cost effective and efficient means of testing their therapeutics and taking them to market. Since its inception, Retroscreen has successfully carried out over 40 clinical studies, involving more than 85 quarantines and in excess of 1800 volunteers for a cross-section of leading industry, governmental and academic clients.

Dr Lambkin-Williams said: “I’m looking forward to attending this well respected annual event.

“I am passionate about the Human Viral Challenge Model and am delighted to have the opportunity to speak during the industry session sponsored by Retroscreen in the evening of 11th November. And we are really proud to have a select group of very eminent scientific colleagues also providing insight into their use of the hVIVO challenge model to help accelerate drug development”

Retroscreen are a sponsor of the RSV 2014 event, and will have an exhibition display stand and a business development presence, led by Mike Lawson, Business Development Director. If you would like to make contact with Retroscreen whilst at the event, please contact Mike Lawson or email  .

To find out more about the RSV 2014 event, visit

Comments are closed here.